Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs

International Journal of Pharmaceutics

Volumn 453, Issue 1, 2013, Pages 198-214

  Lu, Ying ^a   Park, Kinam ^a,b,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Kyung Hee University   (South Korea)

Author keywords

Anticancer; Clinical trial; Drug solubilization; Micelle stability; Nanocrystal; Nanoemulsion; Oral delivery; Polymeric micelle

Indexed keywords

APREPITANT; CISPLATIN; CYCLOSPORIN; CYCLOSPORIN A; DOCETAXEL; DOXORUBICIN; ESTRADIOL; FENOFIBRATE; FIRTECAN; INVENGA; MEGESTROL; MEGESTROL ACETATE; NANOCRYSTAL; NANOPARTICLE; PACLITAXEL; RAPAMYCIN; RITONAVIR; SANDIMMUNNEORAL; SAQUINAVIR; UNCLASSIFIED DRUG;

CANCER THERAPY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; INTESTINE MUCOSA; MICELLE; NANOEMULSION; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SOLUBILIZATION; THERMODYNAMICS;

EID: 85028127551     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.042     Document Type: Review

References (130)

1. Alakhov, V., Klinski, E., Li, S.M., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., Kabanov, A., 1999. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf. B: Biointerfaces 16, 113-134. (Pubitemid 29486800)
2. Arnida, Nishiyama, N., Kanayama, N., Jang, W.D., Yamasaki, Y., Kataoka, K., 2006. PEGylated gene nanocarriers based on block catiomers bearing ethylenediamine repeating units directed to remarkable enhancement of photochemical transfection. J. Control. Release 115, 208-215.
3. Ashok, B., Arleth, L., Hjelm, R.P., Rubinstein, I., Önyüksel, H., 2004. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J. Pharm. Sci. 93, 2476-2487. (Pubitemid 39319431)
4. Bali, V., Ali, M., Ali, J., 2010. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf. B: Biointerfaces 76, 410-420.
5. Barreiro-Iglesias, R., Bromberg, L., Temchenko, M., Hatton, T.A., Concheiro, A., Alvarez-Lorenzo, C., 2004. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. J. Control. Release 97, 537-549. (Pubitemid 38802955)
6. Batrakova, E.V., Han, H.Y., Alakhov, V.Y., Miller, D.W., Kabanov, A.V., 1998. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 15, 850-855. (Pubitemid 28307825)
7. Batrakova, E.V., Li, S., Elmquist, W.F., Miller, D.W., Alakhov, V.Y., Kabanov, A.V., 2001. Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion. Br. J. Cancer 85, 1987-1997. (Pubitemid 34775338)
8. Buchanan, C.M., Buchanan, N.L., Edgar, K.J., Lambert, J.L., Posey-Dowty, J.D., Ramsey, M.G., Wempe, M.F., 2006. Solubilization and dissolution of tamoxifenhydroxybutenyl cyclodextrin complexes. J. Pharm. Sci. 95, 2246-2255. (Pubitemid 44568534)
9. Burris, H.A., 2008. A phase I dose-escalation study of NK012. J. Clin. Oncol. 26, 2538.
10. Burt, H.M., Zhang, X.C., Toleikis, P., Embree, L., Hunter, W.L., 1999. Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf. B: Biointerfaces 16, 161-171. (Pubitemid 29486803)
11. Butcher, J.C., Garg, S., Kim, D., Sharma, P., 2008. A modified approach to predict dissolution and absorption of polydisperse powders. Pharm. Res. 25, 2309-2311.
12. Cavallaro, G., Maniscalco, L., Licciardi, M., Giammona, G., 2004. Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies. Macromol. Biosci. 4, 1028-1038. (Pubitemid 39578095)
13. Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N.M., Alving, C.R., Muggia, F.M., 2003. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann. Oncol. 14, 1430-1437. (Pubitemid 37185291)
14. Chang, T., Benet, L.Z., Hebert, M.F., 1996. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 59, 297-303. (Pubitemid 26122201)
15. Chen, H., Kim, S., He, W., Wang, H., Low, P.S., Park, K., Cheng, J.X., 2008. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging. Langmuir 24, 5213-5217.
16. Chen, H.B., Khemtong, C., Yang, X.L., Chang, X.L., Gao, J.M., 2011. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today 16, 354-360.
17. Colin, W.P., 2000. Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci. 11 (Suppl. 2), S93-S98.
18. Constantinides, P.P., Chaubal, M.V., Shorr, R., 2008. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv. Drug Deliv. Rev. 60, 757-767.
19. Dabholkar, R.D., Sawant, R.M., Mongayt, D.A., Devarajan, P.V., Torchilin, V.P., 2006. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int. J. Pharm. 315, 148-157. (Pubitemid 43674120)
20. Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., Ranson, M., 2004. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer. Br. J. Cancer 90, 2085-2091. (Pubitemid 38869710)
21. Daugherty, A.L., Mrsny, R.J., 1999. Transcellular uptake mechanisms of the intestinal epithelial barrier. Part one. Pharm. Sci. Technol. Today 2, 144-151. (Pubitemid 29195747)
22. Dey, J., Warner, I.M., 1997. Spectroscopic and photophysical studies of the anticancer drug: camptothecin. J. Lumin. 71, 105-114. (Pubitemid 127412275)
23. Dodiya, S.S., Chavhan, S.S., Sawant, K.K., Korde, A.G., 2011. Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies. J. Microencapsul. 28, 515-527.
24. Elhasi, S., Astaneh, R., Lavasanifar, A., 2007. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles. Eur. J. Pharm. Biopharm. 65, 406-413.
25. Elsabahy, M., Perron, M.E., Bertrand, N., Yu, G.E., Leroux, J.C., 2007. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. Biomacromolecules 8, 2250-2257. (Pubitemid 47104311)
26. Francis, M.F., Cristea, M., Winnik, F.M., 2004. Polymeric micelles for oral drug delivery: why and how. Pure Appl. Chem. 76, 1321-1335.
27. Francis, M.F., Cristea, M., Yang, Y.L., Winnik, F.M., 2005a. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin a across Caco-2 cells. Pharm. Res. 22, 209-219. (Pubitemid 40487204)
28. Francis, M.F., Cristea, M., Winnik, F.M., 2005b. Exploiting the vitamin B-12 pathway to enhance oral drug delivery via polymeric micelles. Biomacromolecules 6, 2462-2467. (Pubitemid 41388255)
29. Ganta, S., Devalapally, H., Baguley, B.C., Garg, S., Amiji, M., 2008. Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. J. Biomed. Nanotechnol. 4, 165-173.
30. Gaucher, G., Dufresne, M.H., Sant, V.P., Kang, N., Maysinger, D., Leroux, J.C., 2005. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release 109, 169-188. (Pubitemid 41742123)
31. Gradishar, W.J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., O'Shaughnessy, J., 2005. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 23, 7794-7803. (Pubitemid 46657376)
32. Green, M.R., Manikhas, G.M., Orlov, S., Afanasyev, B., Makhson, A.M., Bhar, P., Hawkins, M.J., 2006. Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann. Oncol. 17, 1263-1268. (Pubitemid 44288216)
33. Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., Shimada, Y., Nakahama, H., Matsumura, Y., 2007. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br. J. Cancer 97, 170-176. (Pubitemid 47057476)
34. Hamaguchi, T., Doi, T., Eguchi-Nakajima, T., Kato, K., Yamada, Y., Shimada, Y., Fuse, N., Ohtsu, A., Matsumoto, S., Takanashi, M., Matsumura, Y., Phase I, 2010. Study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors. Clin. Cancer Res. 16, 5058-5066.
35. Horn, D., Rieger, J., 2001. Organic nanoparticles in the aqueous phase - theory, experiment, and use. Angew. Chem. Int. Ed. 40, 4330-4361. (Pubitemid 33150759)
36. Horter, D., Dressman, J.B., 2001. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 46, 75-87.
37. Hrkach, J., Von Hoff, D., Ali, M.M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., Low, S., McDonnell, K., Peeke, E., Retnarajan, B., Sabnis, A., Schnipper, E., Song, J.J., Song, Y.H., Summa, J., Tompsett, D., Troiano, G., Hoven, T.V., Wright, J., LoRusso, P., Kantoff, P.W., Bander, N.H., Sweeney, C., Farokhzad, O.C., Langer, R., Zale, S., 2012. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 4.
38. Hu, F.Q., Ren, G.F., Yuan, H., Du, Y.Z., Zeng, S., 2006. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf. B: Biointerfaces 50, 97-103. (Pubitemid 43946659)
39. Ibrahim, N.K., Samuels, B., Page, R., Doval, D., Patel, K.M., Rao, S.C., Nair, M.K., Bhar, P., Desai, N., Hortobagyi, G.N., 2005. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J. Clin. Oncol. 23, 6019-6026.
40. Ishida, T., Maeda, R., Ichihara, M., Irimura, K., Kiwada, H., 2003a. Accelerated clearance of PEGylated liposomes in rats after repeated injections. J. Control. Release 88, 35-42. (Pubitemid 36173950)
41. Ishida, T., Masuda, K., Ichikawa, T., Ichihara, M., Irimura, K., Kiwada, H., 2003b. Accelerated clearance of a second injection of PEGylated liposomes in mice. Int. J. Pharm. 255, 167-174. (Pubitemid 36369600)
42. Jadhav, K.R., Shaikh, I.M., Ambade, K.W., Kadam, V.J., 2006. Applications of microemulsion based drug delivery system. Curr. Drug Deliv. 3, 267-273. (Pubitemid 44031625)
43. Jahn, A., Reiner, J.E., Vreeland, W.N., DeVoe, D.L., Locascio, L.E., Gaitan, M., 2008. Preparation of nanoparticles by continuous-flow microfluidics. J. Nanopartic. Res. 10, 925-934.
44. Jiang, G.H., Wang, Y., Zhang, R., Wang, R.J., Wang, X.H., Zhang, M., Sun, X.K., Bao, S.Y., Wang, T., Wang, S., 2012. Preparation of redox-sensitive shell cross-linked nanoparticles for controlled release of bioactive agents. ACS Macro Lett. 1, 489-493.
45. Jinno, J.-i., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G.G., Higaki, K., Kimura, T., 2006. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release 111, 56-64. (Pubitemid 43289995)
46. Jung, J.-Y., Yoo, S.D., Lee, S.-H., Kim, K.-H., Yoon, D.-S., Lee, K.-H., 1999. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm. 187, 209-218. (Pubitemid 29443901)
47. Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y., 2002. Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 82, 189-212. (Pubitemid 34880178)
48. Kang, N., Leroux, J.-C., 2004. Triblock and star-block copolymers of N-(2-hydroxypropyl)methacrylamide or N-vinyl-2-pyrrolidone and D,L-lactide: synthesis and self-assembling properties in water. Polymer 45, 8967-8980. (Pubitemid 39550629)
49. Kang, J., Kumar, V., Yang, D., Chowdhury, P.R., Hohl, R.J., 2002. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. Eur. J. Pharm. Sci. 15, 163-170. (Pubitemid 34155378)
50. Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., Kwon, G.S., 2000. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release 64, 143-153. (Pubitemid 30035315)
51. Kato, K., Hamaguchi, T., Yasui, H., Okusaka, T., Ueno, H., Ikeda, M., Shirao, K., Shimada, Y., Nakahama, H., Muro, K., Matsumura, Y., 2006. Phase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancer. J. Clin. Oncol. 24, 83S.
52. Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420, 1-10.
53. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., Masuda, K., 2002. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J. Control. Release 81, 65-74. (Pubitemid 34454850)
54. Keck, C.M., Muller, R.H., 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. 62, 3-16. (Pubitemid 41736019)
55. Kim, S.C., Kim, D.W., Shim, Y.H., Bang, J.S., Oh, H.S., Kim, S.W., Seo, M.H., 2001. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 72, 191-202. (Pubitemid 32522357)
56. Kim, T.Y., Kim, D.W., Chung, J.Y., Shin, S.G., Kim, S.C., Heo, D.S., Kim, N.K., Bang, Y.J., Phase I, 2004. and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res. 10, 3708-3716.
57. Kim, D.W., Kim, S.Y., Kim, H.K., Kim, S.W., Shin, S.W., Kim, J.S., Park, K., Lee, M.Y., Heo, D.S., 2007. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009-2014. (Pubitemid 350286241)
58. Kim, J.Y., Kim, S., Papp, M., Park, K., Pinal, R., 2011. Hydrotropic solubilization of poorly water-soluble drugs. J. Pharm. Sci. 99, 3953-3965.
59. Kohori, F., Sakai, K., Aoyagi, T., Yokoyama, M., Sakurai, Y., Okano, T., 1998. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-dl-lactide). J. Control. Release 55, 87-98. (Pubitemid 28477567)
60. Koizumi, F., Kitagawa, M., Negishi, T., Onda, T., Matsumoto, S., Hamaguchi, T., Matsumura, Y., 2006. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res. 66, 10048-10056. (Pubitemid 44672058)
61. Konno, T., Watanabe, J., Ishihara, K., 2003. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J. Biomed. Mater. Res. A 65A, 209-214. (Pubitemid 37521427)
62. Kwon, G.S., 2003. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carrier Syst. 20, 357-403. (Pubitemid 38129592)
63. Laverman, P., Brouwers, A.H., Dams, E.T.M., Oyen, W.J.G., Storm, G., Van Rooijen, N., Corstens, F.H.M., Boerman, O.C., 2000. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J. Pharmacol. Exp. Ther. 293, 996-1001. (Pubitemid 30417869)
64. Lee, S.C., Huh, K.M., Lee, J., Cho, Y.W., Galinsky, R.E., Park, K., 2007. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization. Biomacromolecules 8, 202-208. (Pubitemid 46140493)
65. Lee, K.S., Chung, H.C., Im, S.A., Park, Y.H., Kim, C.S., Kim, S.B., Rha, S.Y., Lee, M.Y., Ro, J., 2008. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res. Treat. 108, 241-250. (Pubitemid 351311357)
66. Lele, B.S., Leroux, J.C., 2002. Synthesis of novel amphiphilic star-shaped poly(e-caprolactone)-block-poly(N-(2-hydroxypropyl)methacrylamide) by combination of ring-opening and chain transfer polymerization. Polymer 43, 5595-5606. (Pubitemid 34919426)
67. Li, X.M., Gu, L., Xu, Y.L., Wang, Y.L., 2009. Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev. Ind. Pharm. 35, 827-833.
68. Licciardi, M., Cavallaro, G., Di Stefano, M., Pitarresi, G., Fiorica, C., Giammona, G., 2010. New self-assembling polyaspartylhydrazide copolymer micelles for anticancer drug delivery. Int. J. Pharm. 396, 219-228.
69. Lipinski, C., 2000. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44, 235-249. (Pubitemid 32239479)
70. Liversidge, G.G., Cundy, K.C., 1995. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125, 91-97.
71. Lu, Y., Qi, J.P., Wu, W., 2012. Absorption, disposition and pharmacokinetics of nanoemulsions. Curr. Drug Metab. 13, 396-417.
72. Lukyanov, A.N., Torchilin, V.P., 2004. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Deliv. Rev. 56, 1273-1289. (Pubitemid 38510474)
73. Mathot, F., Rieux, A.D., Arien, A., Schneider, Y.J., Brewster, M., Preat, V., 2007. Transport mechanisms of mmePEG(750)P(CL-co-TMC) polymeric micelles across the intestinal barrier. J. Control. Release 124, 134-143. (Pubitemid 350110487)
74. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N., 2004. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91, 1775-1781. (Pubitemid 39664964)
75. Meier, M.A.R., Aerts, S.N.H., Staal, B.B.P., Rasa, M., Schubert, U.S., 2005. PEO-b-PCL block copolymers: synthesis, detailed characterization, and selected micellar drug encapsulation behavior. Macromol. Rapid Commun. 26, 1918-1924. (Pubitemid 43051767)
76. Merisko-Liversidge, E.M., Liversidge, G.G., 2008. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol. Pathol. 36, 43-48.
77. Meyer-Losic, F., Nicolazzi, C., Quinonero, J., Ribes, F., Michel, M., Dubois, V., de Coupade, C., Boukaissi, M., Chene, A.-S., Tranchant, I., Arranz, V., Zoubaa, I., Fruchart, J.-S., Ravel, D., Kearsey, J., 2008. DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies. Clin. Cancer Res. 14, 2145-2153. (Pubitemid 351551127)
78. Muller, R.H., Peters, K., 1998a. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int. J. Pharm. 160, 229-237. (Pubitemid 28083096)
79. Muller, R.H., Peters, K., 1998b. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm. 160, 229-237. (Pubitemid 28083096)
80. Nagano, T., Yasunaga, M., Goto, K., Kenmotsu, H., Koga, Y., Kuroda, J., Nishimura, Y., Sugino, T., Nishiwaki, Y., Matsumura, Y., 2010. Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer. Int. J. Cancer 127, 2699-2706.
81. Nagarajan, R., Barry, M., 1986. Unusual selectivity in solubilization by block copolymer micelles. Abstr. Papers Amer. Chem. Soc. 191, 287-290.
82. Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 2001. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 74, 295-302. (Pubitemid 32727635)
83. Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., Kataoka, K., 2003. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63, 8977-8983. (Pubitemid 38064079)
84. Norris, D.A., Puri, N., Sinko, P.J., 1998. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev. 34, 135-154. (Pubitemid 28535109)
85. O'Leary, J., Muggia, F.M., 1998. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer 34, 1500-1508. (Pubitemid 28446329)
86. Onoue, S., Sato, H., Ogawa, K., Kawabata, Y., Mizumoto, T., Yuminoki, K., Hashimoto, N., Yamada, S., 2010. Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. Int. J. Pharm. 399, 94-101.
87. Opanasopit, P., Ngawhirunpat, T., Chaidedgumjorn, A., Rojanarata, T., Apirakaramwong, A., Phongying, S., Choochottiros, C., Chirachanchai, S., 2006. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system. Eur. J. Pharm. Biopharm. 64, 269-276. (Pubitemid 44585206)
88. Ould-Ouali, L., Noppe, M., Langlois, X., Willems, B., Riele, P.T., Timmerman, P., Brewster, M.E., Arien, A., Preat, V., 2005a. Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone. J. Control. Release 102, 657-668. (Pubitemid 40170208)
89. Ould-Ouali, L., Noppe, M., Langlois, X., Willems, B., Te Riele, P., Timmerman, P., Brewster, M.E., Arien, A., Preat, V., 2005b. Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone. J. Control. Release 102, 657-668. (Pubitemid 40170208)
90. Park, K., Kim, J.H., Nam, Y.S., Lee, S., Nam, H.Y., Kim, K., Park, J.H., Kim, I.S., Choi, K., Kim, S.Y., Kwon, I.C., 2007. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J. Control. Release 122, 305-314. (Pubitemid 47404663)
91. Patel, R.B., Patel, B.G., Patel, M.R., Bhatt, K.K., 2010a. HPTLC Method development and validation for analysis of risperidone in formulations, and in vitro release study. Acta Chromatogr. 22, 549-567.
92. Patel, R.B., Patel, M.R., Bhatt, K.K., Patel, B.G., 2010b. HPTLC method development and validation: quantification of paliperidone in formulations and in vitro release study. Anal. Methods 2, 525-531.
93. Peltier, S., Oger, J.M., Lagarce, F., Couet, W., Benoit, J.P., 2006. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res. 23, 1243-1250. (Pubitemid 43946146)
94. Peng, Z.P., Liu, X.X., Tong, Z., 2009. Effect of hydrophobic blocks on the aggregrate behavior of amphiphilic triblock copolymers in aqueous solution. Acta Polym. Sin. 9, 936-941.
95. Pierri, E., Avgoustakis, K., 2005. Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin. J. Biomed. Mater. Res. A 75A, 639-647. (Pubitemid 47233448)
96. Plummer, R., Wilson, R.H., Calvert, H., Boddy, A.V., Griffin, M., Sludden, J., Tilby, M.J., Eatock, M., Pearson, D.G., Ottley, C.J., Matsumura, Y., Kataoka, K., Nishiya, T., 2011. A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br. J. Cancer 104, 593-598.
97. Preetham, A.C., Satish, C.S., 2011. Formulation of a poorly water-soluble drug sirolimus in solid dispersions to improve dissolution. J. Dispers. Sci. Technol. 32, 778-783.
98. Qiu, L.Y., Zheng, C., Jin, Y., Zhu, K.J.E., 2007. Polymeric micelles as nanocarriers for drug delivery. Expert Opin. Ther. Patents 17, 819-830.
99. Rapoport, N., 2004. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int. J. Pharm. 277, 155-162. (Pubitemid 38670430)
100. Ruan, G., Feng, S.S., 2003. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24, 5037-5044. (Pubitemid 37242983)
101. Sant, V.P., Smith, D., Leroux, J.C., 2005. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. J. Control. Release 104, 289-300. (Pubitemid 40724930)
102. Satturwar, P., Eddine, M.N., Ravenelle, F., Leroux, J.C., 2007. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth) acrylate-co-methacrylic acid): Influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur. J. Pharm. Biopharm. 65, 379-387.
103. Schiller, C., Frohlich, C.P., Giessmann, T., Siegmund, W., Monnikes, H., Hosten, N., Weitschies, W., 2005. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22, 971-979. (Pubitemid 41634879)
104. Sheu, M.T., Chen, S.Y., Chen, L.C., Ho, H.O., 2003. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J. Control. Release 88, 355-368.
105. Shono, Y., Jantratid, E., Kesisoglou, F., Reppas, C., Dressman, J.B., 2010. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. Eur. J. Pharm. Biopharm. 76, 95-104.
106. Sinha, S., Ali, M., Baboota, S., Ahuja, A., Kumar, A., Ali, J., 2010. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 11, 518-527.
107. Sonneville-Aubrun, O., Simonnet, J.T., L'Alloret, F., 2004. Nanoemulsions: a new vehicle for skincare products. Adv. Colloid Interface Sci. 108, 145-149.
108. Soppimath, K.S., Tan, D.C.W., Yang, Y.Y., 2005. pH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery. Adv. Mater. 17, 318.
109. Stapert, H.R., Nishiyama, N., Jiang, D.L., Aida, T., Kataoka, K., 2000. Polyion complex micelles encapsulating light-harvesting ionic dendrimer zinc porphyrins. Langmuir 16, 8182-8188.
110. Sylvestre, J.-P., Tang, M.-C., Furtos, A., Leclair, G., Meunier, M., Leroux, J.-C., 2011. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. J. Control. Release 149, 273-280.
111. Szebeni, J., 2005. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 216, 106-121. (Pubitemid 41712000)
112. Tadros, T., Izquierdo, R., Esquena, J., Solans, C., 2004. Formation and stability of nanoemulsions. Adv. Colloid Interface Sci. 108, 303-318.
113. Taillefer, J., Jones, M.C., Brasseur, N., van Lier, J.E., Leroux, J.C., 2000. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. J. Pharm. Sci. 89, 52-62. (Pubitemid 30080154)
114. Talelli, M., Rijcken, C.J.F., van Nostrum, C.F., Storm, G., Hennink, W.E., 2010. Micelles based on HPMA copolymers. Adv. Drug Deliv. Rev. 62, 231-239.
115. Tian, M., Qin, A., Ramireddy, C., Tuzar, Z., Munk, P., 1993. Hybridization of block-copolymer micelles. Abstr. Papers Amer. Chem. Soc. 206, 89-PMSE.
116. Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., Kakizoe, T., 2005. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br. J. Cancer 93, 678-687. (Pubitemid 41486459)
117. Valle, J.W., Armstrong, A., Newman, C., Alakhov, V., Pietrzynski, G., Brewer, J., Campbell, S., Corrie, P., Rowinsky, E.K., Ranson, M., 2011. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest. New Drugs 29, 1029-1037.
118. Van Eerdenbrugh, B., Van den Mooter, G., Augustijns, P., 2008. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 364, 64-75.
119. van Stam, J., Creutz, S., De Schryver, F.C., Jerome, R., 2000. Tuning of the exchange dynamics of unimers between block copolymer micelles with temperature, cosolvents, and cosurfactants. Macromolecules 33, 6388-6395.
120. Vangeyte, P., Gautier, S., Jerome, R., 2004. About the methods of preparation of poly(ethylene oxide)-b-poly(epsilon-caprolactone) nanoparticles in water analysis by dynamic light scattering. Colloids Surf. Physicochem. Eng. Asp. 242, 203-211. (Pubitemid 38981591)
121. Wang, Y.M., Balaji, R., Quirk, R.P., Mattice, W.L., 1992. Detection of rate of the rate of exchange of chains between micelles formed by diblock copolymers in aqueous solution. Polym. Bull. 28, 333-338.
122. Wei, H., Cheng, S.X., Zhang, X.Z., Zhuo, R.X., 2009. Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers. Prog. Polym. Sci. 34, 893-910.
123. Woodle, M.C., Engbers, C.M., Zalipsky, S., 1994. New amphipatic polymer lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjugate Chem. 5, 493-496.
124. Xia, D., Cui, F., Piao, H., Cun, D., Piao, H., Jiang, Y., Ouyang, M., Quan, P., 2010. Effect of crystal size on the dissolution and oral absorption of nitrendipine in rats. Pharm. Res. 27, 1965-1976.
125. Yang, L., Wu, X.H., Liu, F., Duan, Y.R., Li, S.M., 2009. Novel biodegradable polylactide/poly(ethylene glycol) micelles prepared by direct dissolution method for controlled delivery of anticancer drugs. Pharm. Res. 26, 2332-2342.
126. Yi, Y., Yoon, H.J., Kim, B.O., Shim, M., Kim, S.O., Hwang, S.J., Seo, M.H., 2007. A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J. Control. Release 117, 59-67. (Pubitemid 46161866)
127. Yu, J.M., Li, Y.J., Qiu, L.Y., Jin, Y., 2009. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in vitro and in vivo characterization. J. Pharm. Pharmacol. 61, 713-719.
128. Zastre, J., Jackson, J., Bajwa, M., Liggins, R., Iqbal, F., Burt, H., 2002. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. Eur. J. Pharm. Biopharm. 54, 299-309. (Pubitemid 35341830)
129. Zhang, X.C., Burt, H.M., VonHoff, D., Dexter, D., Mangold, G., Degen, D., Oktaba, A.M., Hunter, W.L., 1997. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother. Pharmacol. 40, 81-86. (Pubitemid 27160966)
130. Zhang, L., Katapodi, K., Davis, T.P., Barner-Kowollik, C., Stenzel, M.H., 2006. Using the reversible addition-fragmentation chain transfer process to synthesize core-crosslinked micelles. J. Polym. Sci. A: Polym. Chem. 44, 2177-2194.